PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences (PRAH) PT Raised to $116 at Credit Suisse
August 7, 2020 6:30 AM EDTCredit Suisse analyst Erin Wilson Wright raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $116.00 (from $113.00) while maintaining a Outperform rating.... More
PRA Health Sciences (PRAH) PT Raised to $130 at Jefferies
August 7, 2020 4:32 AM EDTJefferies analyst David Windley raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $130.00 (from $120.00) while maintaining a Buy rating.... More
PRA Health Sciences (PRAH) Tops Q2 EPS by 3c, Revenues Beat: Offers FY20 EPS Outlook Above Consensus, FY20 Revenue Mid-Point View Above Consensus
August 6, 2020 5:33 PM EDTPRA Health Sciences (NASDAQ: PRAH) reported Q2 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $729.9 million versus the consensus estimate of $716.72 million.
Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million of total revenue; representing a decrease of 4.4% at actual foreign exchange rates and 3.8% on a constant currency basisConsidering the very difficult circumstances, I was delighted with our second quarter financial results. We reported... More
